文献速递类风湿关节炎

早期类风湿关节炎患者自评症状「满意」的长期结局

Long-term outcomes of patients who rate symptoms of rheumatoid arthritis as 'satisfactory'.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

基于英国多中心队列 Rheumatoid Arthritis Medication Study,分析 1127 例起始甲氨蝶呤的早期 RA 患者。基线 572 例(50.8%)处于患者可接受症状状态(PASS),其一年内 DAS28 与 HAQ 均优于 N-PASS 患者。基线 PASS 组内识别出六个症状聚类,高疾病活动伴高患者报告结局(PROM)或中等疾病活动伴高 PROM 的聚类结局最差。

要点

  • 基线 PASS 患者一年内 DAS28 平均差 -0.71(95% CI -0.83, -0.59),HAQ 平均差 -0.48(95% CI -0.56, -0.41),均优于 N-PASS。
  • 基线 PASS 组内存在六个症状聚类,高 PROM 的聚类对治疗反应较差。
  • 自评「满意」不代表低疾病活动,高 PROM 者仍需加强关注以优化结局。

核心结论

  • 尽管自评症状「满意」,早期 RA 中高 PROM 评分者治疗反应较差,可能需要更密切监测以优化结局。

研究设计与样本

  • 数据来自英国多中心队列 Rheumatoid Arthritis Medication Study,纳入起始甲氨蝶呤的 RA 患者。
  • 基线、6 个月和 12 个月收集 HAQ、DAS28 及其他患者报告结局指标(PROM)。
  • 以「考虑一般功能与当前疼痛,您当前状况是否满意?」回答「是」定义为 PASS,回答「否」定义为 N-PASS。
  • 采用 K-medians 聚类分析识别基线 PASS 组的症状聚类,并用随机效应模型比较结局。

主要发现

  • 1127 例患者中 572 例(50.8%)基线处于 PASS。
  • 一年内基线 PASS 患者较 N-PASS 患者 DAS28 平均差 -0.71(95% CI -0.83, -0.59)。
  • 一年内基线 PASS 患者较 N-PASS 患者 HAQ 平均差 -0.48(95% CI -0.56, -0.41)。
  • 基线 PASS 组内识别出六个症状聚类,高疾病活动伴高 PROM 或中等疾病活动伴高 PROM 的聚类结局最差。

临床怎么用

  • 对自评症状「满意」的早期 RA 患者,仍需评估 PROM 与疾病活动度,高 PROM 者应加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe outcomes of patients with early RA in a patient acceptable symptom state (PASS) at treatment initiation and to identify clusters of symptoms associated with poor outcomes. METHODS: Data came from the Rheumatoid Arthritis Medication Study, a UK multicentre cohort study of RA patients starting MTX. The HAQ, DAS28 and other patient-reported outcome measures (PROMs) were collected at baseline, and at 6 and 12 months. Patients answering yes to the question 'Is your current condition satisfactory, when you take your general functioning and your current pain into consideration?' were defined as PASS; patients answering no were defined as N-PASS. Symptom clusters in the baseline PASS group were identified using K-medians cluster analysis. Outcomes of baseline PASS vs N-PASS patients and each cluster are compared using random effects models. RESULTS: Of 1127 patients, 572 (50.8%) reported being in PASS at baseline. Over one year, baseline PASS patients had lower DAS28 (mean difference = -0.71, 95% CI -0.83, -0.59) and HAQ scores (mean difference = -0.48, 95% CI -0.56, -0.41) compared with N-PASS patients. Within the baseline PASS group, we identified six symptom clusters. Clusters characterized by high disease activity and high PROMs, or moderate disease activity and high PROMs, had the worst outcomes compared with the other clusters. CONCLUSION: Despite reporting their condition as 'satisfactory', early RA patients with high PROM scores are less likely to respond to therapy. This group may require increased vigilance to optimize outcomes.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Gwinnutt JM, Hyrich KL, Lunt M, et al. Long-term outcomes of patients who rate symptoms of rheumatoid arthritis as 'satisfactory'. Rheumatology (Oxford). 2020. PMID: 31729526. doi:10.1093/rheumatology/kez497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。